Newsfile Corp

IN THE PRESS

Press Releases

Marvel to File for Orphan Drug Designation with The U.S. FDA for MB-204 as a Treatment for Rett Syndrome

March 17, 2025

·

4 min read

Press Releases

Biophytis Revolutionizes Sarcopenia

March 17, 2025

·

3 min read

Press Releases

Neural Therapeutics Commences Trading, Provides Update on Growth Initiatives and Engages Investor Relations Consultants

March 17, 2025

·

8 min read

Press Releases

NervGen Pharma Grants Stock Options

March 17, 2025

·

1 min read

Press Releases

Medexus Completes Agreement to Return US Commercialization Rights for Gleolan to NX Development Corp.

March 14, 2025

·

4 min read

Press Releases

Neural Therapeutics Announces Closing of Financing, CSE Listing Approval, Completion of Previously Announced Transactions and Corporate Updates

March 13, 2025

·

12 min read

Press Releases

Adaptimmune to Report Full Year and Q4 2024 Financial and Business Updates on Thursday, March 20, 2025

March 13, 2025

·

2 min read

Press Releases

Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC

March 13, 2025

·

4 min read

Press Releases

Marvel Announces First of Two Final Data Sets from Rett Syndrome Study: MB-204 Significantly Outperforms Trofinetide

March 13, 2025

·

5 min read

Press Releases

Kiora Pharmaceuticals to Present Preclinical Data on KIO-104 for the Treatment of Proliferative Vitreoretinopathy at the ARVO 2025 Annual Meeting

March 12, 2025

·

4 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750